Devices, digital health, and the technology changing how care is delivered.
The issue is not only functional. It is experiential. Many women do not need more scores. They need continuity, context, and support that feels companionable rather than corrective. The post Women’s Health Is Not a Wearable Feature — It’s an Operating System Problem appeared first on MedCity News .
Digital health solutions are booming, but a critical roadblock stands in the way: the lack of a common quality framework. Purchasers seek greater transparency from vendors regarding how their solutions engage members and improve health outcomes, while vendors need better data on the members they serve to provide more effective support. NCQA is launching a […] The post NCQA Launches Digital Health Engagement Accreditation Program appeared first on NCQA .
Here’s how alternative care pathways are changing the way we think about patient discharge and how to create effective and safe disposition options from both emergency department (ED) and inpatient settings. The post Care Without Walls: Scaling Alternatives to Skilled Nursing Facilities appeared first on MedCity News .
The biotech IPOs window is now open, but that doesn’t mean every company can go through it. A panel at the BIO Convention in San Diego discussed the steps biotech companies should take if they’re considering a public listing. The post The Things to Think About Before Taking Your Biotech Company Public appeared first on MedCity News .
Cadence raised $100 million in Series C funding to scale its AI-powered chronic care platform, which monitors patients at home and adjusts their medications in real time. The startup, now valued at $1.23 billion, partners with health systems to treat patients with heart failure, hypertension and diabetes. The post Cadence Rakes In $100M to Automate Chronic Care at Scale appeared first on MedCity News .
Ladder Health’s seed round was led by Nina Capital, with participation from Mairs & Power Venture Capital, South Dakota First Capital, 25madison Health, Hatteras Venture Partners, Create Health Ventures, Jumpstart Capital, White Oak Enterprises, Groove Capital and 7Rock Ventures. The post Startup Raises $7M for Virtual-First Pediatric Therapy Model appeared first on MedCity News .
Guidance Recap Podcast | Digital Health Technologies for Remote Data Acquisition in Clinical Investigations
Eric Lenard comes to the new position with more than two decades of experience in medtech finance, as Medtronic steps up its investment in innovation.
Divakar Ramakrishnan brings experience from Convatec and Eli Lilly. Insulet said the new hire was an important step in strengthening the company’s innovation capabilities.
Organizations that are experiencing significant improvements related to AI are not necessarily using more advanced tools. They are just using the tools they have with more intention. The post Why Healthcare AI is Missing the Point appeared first on MedCity News .
Providers don’t need to endorse ibogaine treatment to take this moment seriously. They need to understand it, respect the risk, and prepare for those already seeking it. The post Ibogaine and SUD Treatment: Signal, Risk, and the Role of Providers appeared first on MedCity News .
This is not an abstract discussion. It is about sustaining the organizations, employees, and communities that depend on us. If we fail to account for how these policies interact in the real world, we risk weakening the very system we are trying to improve. The post Washington’s Medical Debt Push Risks Missing the Bigger Healthcare Crisis appeared first on MedCity News .
Appeals and grievances reflect how well a health plan functions under pressure. They also show how effectively your organization can surface, prioritize, and resolve the cases that matter most. The post Why So Few Appeals Happen and What That Reveals About Health Plans appeared first on MedCity News .
Eli Lilly made good on its threat to withhold 340B drug discounts from hospitals that refused to submit claims data. Hospital groups are calling the policy unlawful, arguing that the company has no legal authority to create its own compliance requirements for a federal program. The post Hospitals Cry Foul After Eli Lilly Withholds 340B Discounts appeared first on MedCity News .
Abarca Health and LucyRx plan to combine to build a larger independent PBM serving more than 9 million members. The post Abarca Health and LucyRx to Combine to Scale Independent PBM Model appeared first on MedCity News .
Digital Health Technologies (DHTs) for Drug Development
The cuts come as Karl Storz plans to retire the Asensus brand and the Senhance robot as part of organizational changes.
Executives with Abbott, PercuSense and Biolinq spoke with MedTech Dive about what’s next with multi-analyte sensor technology.
J&J’s Abiomed and manufacturing partner Oscor warned of a bleeding risk from devices used to introduce catheters to the body.
Alternative health plan designs represent much more than a passing trend. They are actively testing long-standing assumptions about how benefits should be structured, delivered, and experienced. The post Alternative Health Plan Designs Are Reshaping Employer Benefits appeared first on MedCity News .
For governments and health systems, monoclonal antibodies represent not just another drug class, but a strategic shift toward precision prevention. The post Passive Immunization: The Expanding Role of Monoclonal Antibodies in Preventive Medicine appeared first on MedCity News .
Objectives To develop phenotype algorithms for the detection of adverse events (AEs) or AE-proxies in electronic health records (EHRs), accounting for varying data availability. Design Multicentre study conducted as part of the Use Case POLAR_MI (POLypharmacy, drug interActions, Risks) of the German Medical Informatics Initiative (MII). Setting Germany. Participants Multidisciplinary teams from 10 German university sites within the MII. Interventions Not applicable. Main outcome measures Literature- and consensus-based development and operationalisation of AE algorithms using structured EHR…
We’re entering uncharted territory if bad actors can both launch zero-days and exploit unaddressed backdoors with new efficiency. This is why teams need to unify their network structure and better forecast what they’re up against. The post Preparing Healthcare Networks For The Vulnerability Flood appeared first on MedCity News .
Bionyra Pharma’s pipeline includes two drugs that target the signaling protein TL1A, alone and as part of a combination approach to treat inflammatory disorders. The startup’s launch makes it a contender in an emerging drug class that includes late-clinical assets from Merck, Roche, and partners Sanofi and Teva Pharmaceuticals. The post Inflammation Startup Bionyra Launches With $165M and Ex-Sanofi Exec at the Helm appeared first on MedCity News .